Your browser doesn't support javascript.
loading
Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study.
Fukasawa, Satoshi; Suzuki, Hiroyoshi; Kawaguchi, Kazushiro; Noguchi, Hidehisa; Enjo, Kentaro; Tran, Namphuong; Todd, Mary; Fizazi, Karim; Matsubara, Nobuaki.
Affiliation
  • Fukasawa S; Prostate Center and Division of Urology, Chiba Cancer Center.
  • Suzuki H; Department of Urology, Toho University Sakura Medical Center, Chiba.
  • Kawaguchi K; Janssen Pharmaceutical K.K, Tokyo, Japan.
  • Noguchi H; Janssen Pharmaceutical K.K, Tokyo, Japan.
  • Enjo K; Janssen Pharmaceutical K.K, Tokyo, Japan.
  • Tran N; Janssen Research & Development, Los Angeles, CA, USA.
  • Todd M; Janssen Research & Development, Raritan, NJ, USA.
  • Fizazi K; Institut Gustave Roussy, Paris-Sud University, Villejuif, France.
  • Matsubara N; Department of Breast and Medical Oncology, National Cancer Center Hospital East, Chiba, Japan.
Jpn J Clin Oncol ; 48(11): 1012-1021, 2018 Nov 01.
Article in En | MEDLINE | ID: mdl-30371895

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Prednisone / Asian People / Abiraterone Acetate Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Jpn J Clin Oncol Year: 2018 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Prednisone / Asian People / Abiraterone Acetate Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Jpn J Clin Oncol Year: 2018 Type: Article